Aby J. Mathew, Ph.D.

Dr. Mathew was part of the founding team of BioLife Solutions, Inc., and is a co-developer of BioLife’s biopreservation media solutions. He is a co-inventor on multiple issued and pending patents related to methods, devices, and formulations for the preservation of cells, tissues, and organs. He holds a Ph.D. in Biological Sciences within the Biochemistry,…

Read More

Andrew Hinson

(Member – Compensation, Corporate Governance Committees) Andrew Hinson joined the Board in February 2007. Mr. Hinson served as Vice President of Clinical and Regulatory Affairs for LoneStar Heart, Inc. from 2004 to 2016. Mr. Hinson previously served as the Senior Director of research and clinical development at AnGes MG, Inc. (TSE: 4563) a biotechnology firm…

Read More

Anthony Davies, Ph.D.

Dr. Davies is Founder and CEO of Dark Horse Consulting, a boutique practice focused on CMC and product development issues in cell and gene therapy. After training as a biochemist, chemical engineer and molecular biologist, Dr. Davies has worked in the cell and gene therapy field for some 20 years. He brings with him an…

Read More

Colleen Delaney, M.D., M.Sc.

Scientific Founder and Chief Medical Officer of Nohla Therapeutics, Inc., a cellular therapy company focused on the development of universal donor cell therapies for patients with hematologic malignances and other critical diseases. Dr. Delaney is also a Member and the Madeline Dabney Adams Endowed Chair in AML Research of the Fred Hutchinson Cancer Research Center…

Read More

Dayong Gao, Ph.D.

Professor of Biomedical Engineering at the University of Washington in Seattle. Dr. Gao has been actively engaged in cryopreservation research for more than 20 years, and has authored over 130 peer-reviewed journal articles on cryopreservation.

Read More

Edward LeCluyse, Ph.D.

Senior Research Investigator at The Hamner Institutes for Health Sciences. Dr. LeCluyse pioneered the use of HypoThermosol® and CryoStor® in improving preservation of research designated livers and derived commercial hepatocytes marketed to the pharmaceutical industry.

Read More

Erik Woods, Ph.D., HCLD(ABB)

Co-Founder and Chief Science Officer at Ossium Health, Inc., a company developing the first cryopreserved bone marrow bank from deceased organ and tissue donors.  Dr. Woods is also a Visiting Professor at the Indiana University School of Medicine, where he has held an Adjunct position since 2003.  Dr. Woods has devoted his career to advancing…

Read More

Jason Acker, MBA, Ph.D.

Dr. Acker is a Senior Research Scientist with the Canadian Blood Services and a Professor in the Department of Laboratory Medicine and Pathology at the University of Alberta, Edmonton, Canada. He received his Bachelor of Science, Master of Science in Experimental Pathology and PhD in Medical Sciences degrees from the University of Alberta. Dr. Acker was a…

Read More

Jerry E. Cooley, M.D.

Dr. Cooley is a board certified dermatologist and diplomate of the American Board of Hair Restoration Surgery (ABHRS). He has served in leadership positions including President of the International Society of Hair Restoration Surgery (ISHRS) and co-editor of the Hair Transplant Forum, the main journal for hair transplant doctors. He has been performing hair transplants…

Read More

John McMannis, Ph.D.

Executive Vice President of Manufacturing at Mesoblast Limited (ASX: MSB; OTC ADR: MBLTY). Dr. McMannis was previously the Director, Cellular Therapy Laboratory, Department of Stem Cell Transplantation, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.

Read More